newsfilter
← Latest News
FDA Approved Drugs·

Approval of Jemperli, Bla #761174

Approval Date: 10/19/2026; Drug Name: Jemperli, Bla #761174; Active Ingredients: DOSTARLIMAB-GXLY; Company: Glaxosmithkline; Submission Status: Approval; Application Number: 761174

Company
GLAXOSMITHKLINE
Keywords
GLAXOSMITHKLINE